Imaging & Diagnostics

Cerebriu Secures €17.4M to Enhance MRI Workflows with AI Platform Apollo
Imaging & Diagnostics Cerebriu Secures €17.4M to Enhance MRI Workflows with AI Platform Apollo

Cerebriu, a Danish startup focused on AI-driven solutions aimed at improving MRI workflows, has achieved a significant milestone by securing €17.4 million in Series A funding. This investment round was led by North Ventures with additional participation from EIFO and Sagitta Ventures. Funding

DeepLook Medical Secures Series A for AI-Powered Breast Cancer Detection
Imaging & Diagnostics DeepLook Medical Secures Series A for AI-Powered Breast Cancer Detection

DeepLook Medical, a pioneering healthtech company focused on advancing medical imaging technology, has announced the successful securing of its Series A funding. Marking the 11th investment from Xcellerant VC Fund 1, this milestone is set to propel the company forward in its mission. Alongside the

Exact Sciences Advances Blood Test for Colorectal Cancer Detection
Imaging & Diagnostics Exact Sciences Advances Blood Test for Colorectal Cancer Detection

The landscape of non-invasive cancer screening technologies is evolving rapidly, with notable advancements in colorectal cancer detection. Among the companies making significant strides, Exact Sciences stands out. Recently, Exact Sciences unveiled promising data regarding its innovative blood-based

Sheba Medical Center Launches embARC Ventures for HealthTech Startups
Imaging & Diagnostics Sheba Medical Center Launches embARC Ventures for HealthTech Startups

In a strategic move to bolster health technology innovations, Sheba Medical Center in Israel has unveiled embARC Ventures, an ambitious initiative that seeks to support startups in the medical field. Announced during the annual meeting of Sheba's ARC Innovation Center, embARC Ventures aims to

FDA Approves Illumina's Pan-Cancer Genomic Profiling Test for Therapy
Imaging & Diagnostics FDA Approves Illumina's Pan-Cancer Genomic Profiling Test for Therapy

The FDA's recent approval of Illumina's TruSight Oncology (TSO) Comprehensive, an in vitro diagnostic (IVD) biomarker test kit, represents a notable milestone in cancer treatment. This approval paves the way for more personalized and precise therapy options for cancer patients. By harnessing

Innovations and Market Dynamics in the Computed Tomography Industry
Imaging & Diagnostics Innovations and Market Dynamics in the Computed Tomography Industry

The computed tomography (CT) scanner industry has experienced rapid growth and significant advancements, transforming how healthcare professionals approach diagnosis and treatment planning. This article delves into the key innovations driving the market, industry trends, and the factors shaping its

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later